Novogen (NVGN) Stock Falls Today on Private Placement

NEW YORK (TheStreet) -- Shares of Novogen  (NVGN) fell 16.79% to $7.68 in late morning trading Monday after the Australian and U.S. biotechnology company announced it had conducted a private placement and offered rights to shareholders.

The company announced late Monday that it agreed to issue approximately 51 million fully-paid ordinary shares plus one attaching 6-month option and half of one attaching 5-year option for every ordinary share issued to institutional investors in the U.S. in a private placement.

The company expects aggregate gross proceeds of approximately AU$15.5 million from the placement, which is expects to close on or about April 24. 

Novogen will also undertake a 1-for-6 non-renounceable rights issue offering of fully-paid ordinary shares to raise up to a maximum of approximately AU$15 million.

More than 2 million shares had changed hands as of 11:50 a.m., compared to the daily average volume of 1,133,600.

NVGN ChartNVGN data by YCharts

More from Markets

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Trump Tariff Threat, Deutsche Bank, Elon Musk and Apple - 5 Things You Must Know

Trump Tariff Threat, Deutsche Bank, Elon Musk and Apple - 5 Things You Must Know

Automakers Slump as Trump Launches National Security Probe into US Car Imports

Automakers Slump as Trump Launches National Security Probe into US Car Imports

Deutsche Bank Confirms Massive Job Cuts as New CEO Christian Sewing Plants Flag

Deutsche Bank Confirms Massive Job Cuts as New CEO Christian Sewing Plants Flag

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market